CVS Health’s iShares iBoxx $ Investment Grade Corporate Bond ETF LQD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$7.15M Hold
70,000
– – 1.67% 16
2026
Q2
$7.63M Buy
+70,000
New +$7.63M 3.39% 10
2023
Q4
– Sell
-930
Closed -$94.9K – 7
2023
Q3
$94.9K Hold
930
– – 0.05% 9
2023
Q2
$101K Hold
930
– – 0.05% 9
2023
Q1
$102K Buy
+930
New +$101K 0.06% 9

Other funds holding LQD

CVS Health's LQD Position: Q3 2026 in Review

CVS Health held its iShares iBoxx $ Investment Grade Corporate Bond ETF (LQD) position steady in Q3 2026 at 70,000 shares worth $7.15M. The position accounts for 1.67% of the portfolio, ranked #16.

CVS Health first reported a position in LQD in Q1 2023 and has held it in 5 quarters since. The position peaked at $7.63M in Q2 2026. 1,056 funds tracked by Wall St. Rank hold LQD as of Q3 2026.

  • CVS Health held 70,000 shares of iShares iBoxx $ Investment Grade Corporate Bond ETF worth $7.15M as of Q3 2026.
  • CVS Health left its iShares iBoxx $ Investment Grade Corporate Bond ETF share count unchanged in Q3 2026.
  • iShares iBoxx $ Investment Grade Corporate Bond ETF made up 1.67% of CVS Health's portfolio in Q3 2026, its #16 holding.
  • CVS Health first reported a position in iShares iBoxx $ Investment Grade Corporate Bond ETF in Q1 2023 and has held it in 5 quarters since.
  • CVS Health's iShares iBoxx $ Investment Grade Corporate Bond ETF position peaked at $7.63M in Q2 2026.
  • 1,056 funds tracked by Wall St. Rank held iShares iBoxx $ Investment Grade Corporate Bond ETF as of Q3 2026.

Based on CVS Health's 13F filing for Q3 2026, filed 5 Nov 2026.